In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Celltech Chiroscience PLC acquires Medeva PLC for $914mm
04 Jan 2000
In a stock swap, Celltech Chiroscience PLC (CCP) has acquired competitor Medeva PLC, exchanging 34 of its shares for every 100 Medeva shares held. Based on CCP's closing price of $7.87 the day before the announcement, it is paying $2.67 per share of Medeva, representing about a (pr)16% premium to Medeva's pre-announcement price,valuing the transaction at $914mm (UK563mm). CCP shareowners will hold 56% of the combined entity--which will be called the Celltech Group PLC--with Medeva holding the rest. Peter Fellner, Celltech's CEO, will serve in the same capacity at the new company, which will have a $2.1bn pro-forma market cap.
Payment Includes Stock
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?